Publicacions en col·laboració amb investigadors/es de Hospital de Gran Canaria Dr. Negrin (19)

2025

  1. Impact of chronic renin-angiotensin-aldosterone inhibitors on short-term outcomes in patients with acute heart failure presenting to the emergency department. A propensity-matched analysis EAHFE cohort

    International Journal of Cardiology, Vol. 418

2024

  1. Association of intravenous digoxin use in acute heart failure with rapid atrial fibrillation and short-term mortality according to patient age, renal function, and serum potassium

    European Journal of Emergency Medicine, Vol. 31, Núm. 5, pp. 347-355

  2. Clinical features, management in the emergency department and mortality of acute heart failure episodes in patients with chronic obstructive pulmonary disease

    Revista Clinica Espanola

  3. Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes

    European Journal of Internal Medicine, Vol. 127, pp. 126-133

  4. Cross-cultural adaptation, reliability and validity of the Spanish version of the long-term quality of life questionnaire

    Frontiers in Oncology, Vol. 14

  5. Digoxin initiation after an acute heart failure episode and its association with post-discharge outcomes: an international multicenter analysis

    Internal and Emergency Medicine

  6. Effect of early initiation of noninvasive ventilation in patients transported by emergency medical service for acute heart failure

    European Journal of Emergency Medicine, Vol. 31, Núm. 5, pp. 339-346

2023

  1. Impact of congestion and perfusion status in the emergency department on severity of decompensation and short-term prognosis in patients with acute heart failure

    European Heart Journal: Acute Cardiovascular Care, Vol. 12, Núm. 3, pp. 165-174

2022

  1. Ambient temperature and atmospheric pressure at discharge as precipitating factors in immediate adverse events in patients treated for decompensated heart failure

    Internal and Emergency Medicine, Vol. 17, Núm. 7, pp. 2045-2056

  2. Incidence, clinical characteristics, risk factors, and outcomes of upper gastrointestinal bleeding in patients with COVID-19 results of the UMC-19-S12

    Journal of Clinical Gastroenterology, Vol. 56, Núm. 1, pp. E38-E46

  3. Short-term outcomes by chronic betablocker treatment in patients presenting to emergency departments with acute heart failure: BB-EAHFE

    European Heart Journal: Acute Cardiovascular Care, Vol. 11, Núm. 10, pp. 761-771

2021

  1. Acute heart failure in subtropical climates: Clinical characteristics, management, and outcomes in the canary islands versus continental spain — the canar-ica study results

    Emergencias, Vol. 33, Núm. 6, pp. 413-420

  2. Differences in Capacity of High-Density Lipoprotein Cholesterol Efflux Between Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis

    Arthritis Care and Research, Vol. 73, Núm. 11, pp. 1590-1596

  3. Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2

    International Journal of Cardiology, Vol. 330, pp. 268-272

  4. Incidence, risk factors, clinical characteristics and outcomes of deep venous thrombosis in patients with COVID-19 attending the Emergency Department: results of the UMC-19-S8

    European Journal of Emergency Medicine, Vol. 28, Núm. 3, pp. 218-226

2020

  1. Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis

    Rheumatology (Oxford, England), Vol. 59, Núm. 10, pp. 2847-2856

2019

  1. Acute heart failure and adverse events associated with the presence of renal dysfunction and hyperkalaemia. EAHFE- renal dysfunction and hyperkalaemia

    European Journal of Internal Medicine, Vol. 67, pp. 89-96

  2. Influence of the length of hospitalisation in post-discharge outcomes in patients with acute heart failure: Results of the LOHRCA study

    European Journal of Internal Medicine, Vol. 70, pp. 24-32

2006

  1. Fentanilo transdérmico en el tratamiento para el dolor neuropático del lesionado medular

    Rehabilitacion, Vol. 40, Núm. 1, pp. 6-13